Chow Gregory K. 4
4 · Aptose Biosciences Inc. · Filed Mar 14, 2019
Insider Transaction Report
Form 4
Chow Gregory K.
Senior VP & CFO
Transactions
- Purchase
Common Shares
2019-03-13$1.74/sh+10,000$17,394→ 122,014 total - Purchase
Common Shares
2019-03-13$1.79/sh+5,000$8,928→ 127,014 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.735 to $1.74, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.779 to $1.79, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.